Verweise von und zu Adverse drug reactions of the skin
Zurück zum ArtikelVerweise von anderen Artikeln
- Adiposity skin changes
- Ambroxol
- Anaphylactic shock
- Angioimmunoblastic T cell lymphoma
- Antiepileptic drug hypersensitivity
- Drug exanthema maculo-papular
- Drug reaction lymphocytic
- Asymmetric periflexural exanthema of childhood
- Atovaquone/proguanil
- Boston exanthema
- Celecoxib
- Certolizumab pegol
- Ciclosporin a
- Cytokine-release syndromes
- Dermatitis exudative discoid lichenoid
- Diclofenac
- Diclofenac
- Drug eruptions
- Dupilumab
- Empact
- Enzyme inhibition
- Erythema
- Exanthema, urticarial
- Asteatotic dermatitis
- Factor xa inhibitors
- Fanconi anaemia
- Febris quintana
- Folliculitis decalvans
- Gingival hyperplasia
- Acute necrotizing ulcerative gingivitis
- Suppurative hidradenitis
- Cough
- Hypersensitivity
- Hypertrichosis, acquired circumscripts
- Ige
- Interface dermatitis
- Interferon alfacon-1
- Interleukin antagonists
- Iododerma tuberosum
- Lichen aureus
- Lini oleum virginale
- Mage-a3
- Malaria
- Measles
- Naproxen
- Papel
- Parecoxib
- Pharmacogenetics
- Pharmacovigilance
- Photoallergic dermatitis
- Pruritus cum materia
- Purpura, drug-induced
- Reaction, acute toxic drug reactions
- Reaction, adverse drug reactions
- Rhinitis drug-induced
- Scarlet fever
- Pregnancy dermatosis polymorphic
- Staphylococcus scarlet fever
- Prurigo simplex acuta
- Syphilide papular
- Thrombosis prophylaxis
- Tuberculosis cutis miliaris disseminata
- Aaw
- Adverse drug reaction
- Adverse drug reaction
- Adverse drug reactions
- Adverse drug reactions
- Valdecoxib
Verweise zu anderen Artikeln
- Ace inhibitors
- Acne medicamentosa
- Acne (overview)
- Acute generalized exanthematous pustulosis
- Alopecia (overview)
- Anaphylaxis
- Angioedema (overview)
- Antihistamines, systemic
- Drug exanthema bullöses
- Drug exanthema lichenoid
- Drug exanthema maculo-papular
- Fixed drug eruption
- Drug reaction lymphocytic
- ASIA
- Beau-reilsche cross furrows of the nails
- Bromoderm
- Bullous Pemphigoid
- Common toxicity criteria
- Coumarin necrosis
- Cytochrome p450 enzymes
- Dermatomyositis (overview)
- Desloratadine
- Dimetinden
- D-Penicillamine
- Dress
- Pressure urticaria
- Dyschromia
- Eosinophilic pustular folliculitis
- Erythema multiforme, minus-type
- Erythema nodosum
- Gingival hyperplasia
- Glucocorticosteroids
- Glucose-6-phosphate dehydrogenase
- Hand-foot syndrome
- Heparin-induced thrombocytopenia
- Hirsutism
- Hiv infection
- Hypertrichoses
- Immune checkpoint inhibitors
- Immune related adverse events
- Immune related adverse events, cutaneous
- Immunological drug reactions
- Granulomatous interstitial Dermatitis with arthritis
- Intolerance reaction
- Koebner phenomenon
- Lichen planus classic type
- Lichen planus (overview)
- Linear IgA dermatosis
- Lupus erythematosus subacute-cutaneous
- Lupus erythematosus (overview)
- Lymphocyte transformation test
- Mastocytosis (overview)
- Mast cell
- Melasma
- Mononucleosis infectious
- N-acetyltransferases
- Nail diseases (overview)
- Neutrophilic eccrine hidradenitis
- Onycholysis drug-induced or light-induced
- Paronychia (overview)
- Pemphigus drug-induced
- Pemphigus diseases (overview)
- Pharmacogenetics
- Photoallergic dermatitis
- Photodermatoses (overview)
- Phototoxic dermatitis
- Porphyria (overview)
- Pruritus
- Pruritus after haes infusions
- Pseudolymphomas of the skin (overview)
- Pseudoporphyria
- Pseudoscleroderma
- Psoriasis (Übersicht)
- Psoriasis vulgaris
- Purpura pigmentosa progressive
- Radiation recall dermatitis
- Sarcoidosis of the skin
- Vaccinations skin changes
- Stevens-johnson syndrome
- Sweet syndrome
- Symmetrical drug related intertriginous and flexural exanthema
- Toxic epidermal necrolysis
- Tyrosine kinase inhibitors
- Urticaria aquagene
- Urticaria chronic spontaneous
- Urticaria (overview)
- UV-recall dermatitis
- Vitiligo (overview)
- Cytostatics (overview)